Dual-Label Peptide Imaging Conjugates

Dual-labeled peptide conjugation for imaging: fluorophore + chelator (radiolabel-compatible), NIR dyes, and defined label placement

Overview

Dual-label peptide imaging conjugates are peptide constructs that contain two distinct imaging handles on a single molecule. In imaging-focused workflows, the most common format is fluorescent labeling combined with a chelator handle that is compatible with downstream radiometal coordination (project-dependent). This architecture supports multimodal readouts by pairing optical detection with chelator-enabled imaging workflows.[2]

Dual-labeled peptides are explored when researchers want to connect cell-based fluorescence assays with downstream imaging workflows, develop dual fluorescence peptide labeling formats for multiplex assays, or evaluate label placement effects on binding and uptake. Successful designs depend on controlled attachment sites, spacer strategy, and label compatibility to preserve peptide function (project-dependent).[3]

Bio-Synthesis provides non-radioactive peptide conjugation for imaging, including dual-labeled peptide conjugates, near-infrared peptide conjugates, and radiolabel-compatible peptide–chelator conjugates as precursor constructs. Bio-Synthesis does not perform radiolabeling or handle radioactive materials. [1]

Dual-labeled peptide conjugates Dual fluorescence peptide labeling Fluorophore + chelator Near-infrared (NIR) Chemically defined with flexible linkers
Branched peptide synthesis schematic showing a lysine branching core with two to eight peptide arms (MAP-2, MAP-4, MAP-8) and dendrimer for multivalent epitope presentation.

Radiolabel-compatible peptide–chelator conjugate architecture (non-radioactive chelator-enabled precursor; radiolabeling performed downstream by end user).

Explore related services: peptide imaging conjugates · peptide–chelator conjugation · peptide–fluorophore conjugates.

Dual-label peptide imaging categories

The categories below cover the most common dual-labeled peptide conjugates used for imaging and assay development. Label selection and feasibility are project-dependent and guided by peptide sequence, attachment site availability, solubility requirements, and the intended imaging workflow.

This dual-label architecture combines an optical label (fluorophore) with a chelator handle that is compatible with downstream radiolabeling workflows (project-dependent). Bio-Synthesis provides the non-radioactive dual-labeled peptide precursor; radiolabeling is performed downstream by the end user in an appropriate facility.

Site-defined dual labeling Fluorophore + chelator PEG/spacer options Purified + confirmed
Representative handles we can incorporate Typical applications Notes
Fluorophore + DOTA/NOTA-family chelator Dual-modality workflows; assay development + downstream imaging tracer preparation (project-dependent) Orthogonal attachment sites help control placement; spacers improve handling
NIR dye + chelator handle Optical imaging with deeper tissue penetration + downstream chelation workflows (project-dependent) Choose dye based on excitation/emission and stability requirements

Fluorophore-labeled peptides are widely used for imaging, receptor binding, internalization studies, and quantitative assays. Dye selection is guided by excitation/emission, brightness, and experimental compatibility (project-dependent).

Representative dye classes Typical applications Notes
Fluorescein / rhodamine families Microscopy, uptake studies, binding assays (project-dependent) Site-defined placement reduces perturbation of peptide function
Cyanine dye families (Cy dyes) Imaging applications requiring brighter signals (project-dependent) Hydrophobicity/charge can affect peptide behavior—spacers may help

NIR peptide conjugates are used when lower autofluorescence and deeper tissue penetration are desired relative to visible dyes. Dye selection and attachment strategy are chosen to preserve peptide binding and improve handling (project-dependent).

Representative NIR dye options Typical applications Notes
NIR cyanine families In vivo optical imaging, biodistribution studies (project-dependent) Use spacers when needed to reduce steric/hydrophobic effects
Dual-label (NIR + chelator) Multimodal workflows combining optical imaging and downstream chelation (project-dependent) Orthogonal attachment sites improve construct definition

Two optical labels can support multiplex assay formats, ratiometric readouts, or parallel tracking in imaging workflows. Orthogonal attachment sites enable controlled placement (project-dependent).

Representative label formats Typical applications Notes
Fluorophore + fluorophore Multiplex detection, internalization, competitive binding assays (project-dependent) Choose dyes with separated emission to reduce channel overlap
Visible dye + NIR dye Two-channel imaging workflows (project-dependent) Design around brightness, stability, and sample background

Typical workflow

1) Define the imaging goal

Choose the dual-label format (fluorophore + chelator, NIR, or dual optical) and confirm the intended imaging or assay workflow.

Share any constraints (buffer, pH, light sensitivity, solubility) early.

2) Site-defined dual conjugation

Install labels on controlled sites (N-/C-terminus, single-Cys, orthogonal handles) to minimize heterogeneity (project-dependent).

PEG/linkers may be used to reduce steric effects and improve handling.

3) Purify & confirm

Purification with fit-for-purpose analytics (HPLC/UPLC; LC–MS when feasible) aligned to label properties and project needs.

Final deliverables are designed for research-stage and preclinical programs.

FAQ

Are fluorophore-labeled peptides the same as imaging peptides?

Fluorophore-labeled peptides are one major type of imaging peptide. “Imaging conjugates” is broader and can include NIR dyes, chelator-enabled (radiolabel-compatible) precursors, or dual-label combinations (project-dependent).

Is a chelator the same as a radiolabel?

No. A chelator is a non-radioactive ligand that can coordinate a metal later. Bio-Synthesis provides chelator–peptide conjugates; radiolabeling is performed downstream by the end user in an appropriate facility.

Can you attach a fluorophore and a chelator to the same peptide?

Yes. We support site-defined dual labeling where the fluorophore and chelator are installed on separate, controlled sites (e.g., N-terminus + single-Cys or handle-enabled options; project-dependent).

Do you support near-infrared (NIR) dye labeling?

Yes. NIR dyes can be incorporated for optical imaging workflows (project-dependent). Dye selection and attachment site are chosen to preserve peptide function and improve handling.

How do you minimize heterogeneity in dual-labeled peptides?

We use site-defined attachment strategies (N-/C-terminus, single-Cys, orthogonal handles, protected side-chains) to control label placement and improve reproducibility (project-dependent).

Can you add PEG/linkers between the peptide and labels?

Yes. PEG or other spacer/linker strategies can reduce steric effects, tune hydrophilicity, and improve solubility/handling (project-dependent).

What analytics do you provide for dual-label conjugates?

Fit-for-purpose confirmation typically includes HPLC/UPLC purity profiling and LC–MS when feasible, aligned to label properties and project needs.

What is a dual-label peptide imaging conjugate?

A dual-label peptide imaging conjugate is a peptide carrying two distinct imaging handles—most commonly a fluorophore plus a chelator (radiolabel-compatible)—to support multimodal or multiplex imaging readouts (project-dependent).

Request a Quote

What to provide
  • Peptide sequence(s) and any preferred attachment site(s)
  • Label combination (e.g., fluorophore + chelator), dye preferences (visible/NIR), and chelator preference (if applicable)
  • Spacer/linker preference (e.g., PEG) and any functional constraints
  • Target quantity, purity target, and intended imaging workflow

Note: Bio-Synthesis provides non-radioactive peptide conjugates. Radiolabeling is performed by the end user.

Share your design details and intended imaging workflow. Our scientists will recommend a compatible site-defined dual-label strategy (project-dependent).

Fastest path

Speak to a Scientist

Full Name *
Email *
Company / Institution *
Phone *
Notes *Please avoid confidential details; we can arrange an NDA if needed.

By submitting, you agree to be contacted regarding your request.

Recommended Reading

  • Dual-Labeled Small Peptides in Cancer Imaging and Fluorescence-Guided Surgery (review) External link
  • Application of radiolabeled peptides in tumor imaging and therapy (review) External link
  • Chemical strategies for site-selective modification of peptides and proteins (review) External link
  • Radiometal chelators and bioconjugation approaches for peptide-based imaging agents (review) External link

Links are provided for reference; access may depend on subscriptions.

Why Choose Bio-Synthesis

Trusted by biotech leaders worldwide for over 40+ years of delivering high quality, fast and scalable synthetic biology solutions.